Literature DB >> 15789811

Arrhythmogenic right ventricular cardiomyopathy in two cats.

A M Harvey1, I A Battersby, M Faena, D Fews, P G G Darke, L Ferasin.   

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease characterised by infiltration of the myocardium by adipose and fibrous tissue. The disease is an important cause of sudden death in humans, but has rarely been described in animals. This report describes ARVC in two cats with right-sided congestive heart failure. One cat had also experienced previous episodes of syncope. Standard six-lead and 24-hour (Holter) electrocardiogram recording revealed complete atrioventricular block and multiform ventricular ectopics in both cats, with the addition of ventricular tachycardia, ventricular bigeminy and R-on-T phenomenon in one of them. On echocardiography, the right ventricle and atrium were massively dilated and hypokinetic. The survival times of the cats were three days and 16 days following diagnosis. Histopathology in one case revealed fibro-fatty infiltration of the myocardium, predominantly affecting the right ventricular free wall.

Entities:  

Mesh:

Year:  2005        PMID: 15789811     DOI: 10.1111/j.1748-5827.2005.tb00306.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  3 in total

1.  Arrhythmogenic right ventricular cardiomyopathy: considerations from in silico experiments.

Authors:  Ronald Wilders
Journal:  Front Physiol       Date:  2012-05-31       Impact factor: 4.566

2.  Long-term management of high-grade atrioventricular block using cilostazol in a cat.

Authors:  Naoki Iwasa; Naohito Nishii; Satoshi Takashima; Yui Kobatake; Saki Nomura; Kazuko Iwasa; Tatsuo Iwasa; Tomomi Suzuki; Noboru Machida; Hitoshi Kitagawa
Journal:  JFMS Open Rep       Date:  2019-10-20

Review 3.  Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models.

Authors:  Giorgia Beffagna; Elena Sommariva; Milena Bellin
Journal:  Front Physiol       Date:  2020-11-12       Impact factor: 4.755

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.